Evidence map›Paper›PMID 35626055›Full record

ReviewCancers2022

Naomie Devico Marciano, Gianna Kroening, Farshid Dayyani, Jason A Zell, Fa-Chyi Lee, May Cho, Jennifer Goldstein Valerin

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Naomie Devico MarcianoDepartment of Medicine, University of California, Irvine, CA 92868, USA.
Gianna KroeningDepartment of Medicine, University of California, Irvine, CA 92868, USA.
Farshid DayyaniDepartment of Medicine, University of California, Irvine, CA 92868, USA.ORCID 0000-0002-4970-5189
Jason A ZellDepartment of Medicine, University of California, Irvine, CA 92868, USA.
Fa-Chyi LeeDepartment of Medicine, University of California, Irvine, CA 92868, USA.
May ChoDepartment of Medicine, University of California, Irvine, CA 92868, USA.
Jennifer Goldstein ValerinDepartment of Medicine, University of California, Irvine, CA 92868, USA.
University of California, Irvine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

The discovery of

Indexed as

BRCAchemotherapyDNA repairpancreatic cancerPARP

Identifiers

PMID35626055
PMCPMC9140002
OpenAlexW4280541445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.